---
title: "ALX Oncology Holdings Inc. (ALXO.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ALXO.US.md"
symbol: "ALXO.US"
name: "ALX Oncology Holdings Inc."
industry: "Biotechnology"
---

# ALX Oncology Holdings Inc. (ALXO.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.alxoncology.com](https://www.alxoncology.com) |

## Company Profile

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic in development as a combination therapy with other anti-cancer agen...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -3.14 | 308/604 | - | - | - |
| PB | 7.58 | 350/604 | 1.64 | 0.85 | 0.28 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-05T05:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 60% |
| Overweight | 1 | 20% |
| Hold | 1 | 20% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.45 |
| Highest Target | 4.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/ALXO.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ALXO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ALXO.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.